chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash this time the size of a soft ball; varicose vein like discoloration; Slightly more pain; Itch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash this time the size of a soft ball), PRURITUS (Itch), VARICOSE VEIN (varicose vein like discoloration) and PAIN (Slightly more pain) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cardiac disorder NOS (Since 10-NOV ) and Unspecified functional disorder of stomach since 01-Jun-2021. Concomitant products included METOPROLOL for Heart disorder, SACUBITRIL VALSARTAN SODIUM HYDRATE (ENTRESTO), LEVOTHYROXINE SODIUM (SYNTHROID), SPIRONOLACTONE (ALDACTONE [SPIRONOLACTONE]) and FAMOTIDINE (PEPCID [FAMOTIDINE]) for an unknown indication.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (Rash this time the size of a soft ball), PRURITUS (Itch), VARICOSE VEIN (varicose vein like discoloration) and PAIN (Slightly more pain). At the time of the report, VACCINATION SITE RASH (Rash this time the size of a soft ball), PRURITUS (Itch) and VARICOSE VEIN (varicose vein like discoloration) had not resolved and PAIN (Slightly more pain) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered PRURITUS (Itch) to be possibly related. No further causality assessments were provided for VACCINATION SITE RASH (Rash this time the size of a soft ball), VARICOSE VEIN (varicose vein like discoloration) and PAIN (Slightly more pain).    Patient reported history of back and knees. Concomitant medication was provided as Blood thinners. No treatment information is provided.   This case was linked to MOD-2021-067280 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow up received on 15-Jul-2021 contains Patient demographics, Concomitant drugs, New events, duration and outcome were added. Reporter causality and event outcomes were updated
Employee received vaccine 9/21/2018, reports hives on 9/22/2018 in the afternoon. States he took BENADRYL with relief of hives. States today 9/24/2018 "I'm totally fine now, last BENADRYL was 9/23/2018 at 11:30 PM".
On 11/10/2016, got a low grade fever, chills, and muscle weakness. By evening 11/11/2016, my fever was much higher, confused, delirious, and bed ridden due to fatigue and muscle aches. On 11/12/2016, my fever broke, going back to low grade temperatures with sporadic chills but a persistent violent and unproductive cough has lingered to today the 11/13/2016.
Vomited x 1 less than 5 minutes post vaccine, otherwise well on exam prior to administration, slight redness to skin area, no new symptoms over next 30 minutes of monitoring.
Initially after receiving the vaccine, I had started bleeding at the injection site. A few days later when I was shopping my upper left thigh, in the front, went numb. It was about the size of a stick of gum. From then on that area has always been numb. Over a month the area got bigger to about the size of a postcard. From February 2021 to August 2021 the thigh was numb everyday. Sometimes it was from my knee to my hips and other times it was a gum size piece. In August I got an appointment with my doctor. He looked at my leg and said that there was a concave on my left thigh where the numbness was. By then the area of numbness was usually half my thigh all the time everyday. I still could walk and do my job. I am out everyday doing stuff. It has been getting worse. My thigh was starting to get numb even in the back getting worse by thanksgiving. I went to my consult with the neurologist. My doctor told me he saw extremities of numbness from patients after receiving the vaccines. I also tested positive for covid on 1/21/2022. I had flu like symptoms, nausea, vomiting, high fever, terrible headache for 3 days, cold, stuffy head, no taste or smell, and tired. I am still very weak from covid.
4 hrs post vax pt felt lightheaded & dizzy then fainted out for 5 min; While out convuls, eye twitching saliva coming out of mouth whole body shaking lasting about 1 min, then whole body went totally limp;
So around the 27th of April, that week, I started having some symptoms. It started out with a posterior headache that became bad and debilitating. I also described the next as a sore throat but it was pain at the front of the neck. I had fever and chills, kind of flu like symptoms. I went to the ER on May 8, 2021. Once the results came back on May 12, 2021 and they said I had group c strep so I got antibiotics - Amoxicillin. I was still feeling terrible so I went to my PCD and she switched me to a z-pac. So around the 18th of May I went in to see her again and she told me to finish the Z-pac and they ran blood tests. A couple days later it showed I was in hyperthyroidism and I lost about ten pounds and that is significant for me. On June 16, 2021 I saw my endocrinologist. I got another blood test on June 29, 2021. Now I am clearly in Hypothyroidism, I feel a little bit better. My HR was 124 resting so I was also put on 25MG of Metoprolol, but now my heart rate is under control. I mainly talked to my Endo about this, but he said it may have better caused by the Janssen vaccine.
Fever 101.6°F. Arm pain. Severe fatigue. Lethargy. Chills. Site swelling with redness and pain. 2 days later nodule swollen and painful in armpit.
Spike in blood pressure starting several days after the second injection. Blood pressure recorded at 163/106
Myocarditis, Chest pain, ST elevation and mildly depressed EF on echo.  Troponin peaked, has leveled at 1000 3 days after presentation, drawing infection labs and administering IVIG.
Tongue swelling, gagging persistant cough; Eyes watered, all symptoms occurred about 3-4 hours after administration. Lips swelled. Nasal congestion. OTC Benadryl treatment, symptoms subsided over the next day or two. No swelling of throat.
tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine, for Covid-19 immunization.  The following information was reported: FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "tired".  Additional information: It was stated that maybe because patient drove 250 miles round trip in a snowstorm on 2nd round. No adverse effects except tired next day.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient was very nervous about getting any shots and we discussed ways to help with her anxiety as well as side effects.  The patient immediately complained of feeling dizzy within seconds of completing the vaccination.  She slumped in her chair and was nonresponsive to me for about 45 seconds.  Color was very ashen. We treated patient by leaning her in the triangle position and she continued to talk to me at that point.  At 10 minutes patient felt fine and was drinking water.  She was observed for about 45 minutes total and felt fine when she left the pharmacy.  She kept stating she hates shots and was really worked up about getting the vaccine.
patient developed sx on 5-8-23 of covid  with shortness of breath, fever, cough, developed septic shock.  admitted at hospital and deceased 5-15-23 with dx of acute hypoxic resp failure, sepsis, acute kidney injury , chronic kidney disease, chf with preserved EF had hypotension not requring vasopressors, given linezolid and zosyn, iv decadron, nebs, full course remdesivir , had code and was unable to be resuscitated
He is having red rashes that burn all over and especially in the joints.   These have occurred on Sept. 10, 14, 15, 23, 30, 2021 and the last one affected his breathing, shortness of breath.    It last from 30 minutes to an hour each time.   He had covid Sept. 1 through the  9th, 2021.
Fever, chills, nausea and vomiting, weakness and soreness at injection site.
Noticed arm pain starting at the shoulder going all the way down to the elbow on the evening of vaccination. After 2 days on 11/12 the patient noted the symptoms were significantly resolving (slight pain at injection site area only).
Patient complaints of headache which improved over time. Patient was evaluated by EMS. Patient given water to hydrate .
patient states she is 65 y/o. She had contact (rode in the car) with granddaughter briefly on 17Mar2021. her granddaughter (21 y/o) recently tested positive for Covid-19 virus.; This is a spontaneous report received from Pfizer-sponsored program A contactable 65-year-old female consumer reported that:  This is a spontaneous report from a contactable consumer (patient). A 65-years-old female patient received bnt162b2 (BNT162B2; solution for injection), dose 2 via an unspecified route of administration on 04Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient states she is 65 y/o. she had contact (rode in the car) with granddaughter briefly on 17mar2021. her granddaughter (21 y/o) recently tested positive for covid-19 virus. She states her grand daughter has a fever and sore throat. Will e-transmit as potential AE. Referred caller to HCP for further discussion. Spoke from attached document - post-vaccination precautions- wearing a mask and social distancing after receiving the vaccine. Outcome of event was unknown.  Information on the lot/batch number has been requested.
Immediate local swelling at injection site increased in size over next 3 minutes to approx. 1" X 1 1/2" with 1/8" induration , after 3 minutes another site of swelling appeared with circumference of 50 cent piece and induration of 1/8".
I gave Kinrix but should be given over the age 4 per manufacture.   no adverse reaction.  Not age appropriate.
This case was reported by a nurse via sales rep and described the occurrence of influenza-like symptoms in a patient who received BEXSERO for prophylaxis. On an unknown date, the patient received the 1st dose of BEXSERO. On an unknown date, less than a day after receiving BEXSERO, the patient experienced influenza-like symptoms, headache, fatigue, respiratory tract congestion, fever and weakness. On an unknown date, the outcome of the influenza-like symptoms, headache, fatigue, respiratory tract congestion, fever and weakness were recovered/resolved. It was unknown if the reporter considered the influenza-like symptoms, headache, fatigue, respiratory tract congestion, fever and weakness to be related to BEXSERO. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that on the same day of vaccination patient experienced flu like symptoms, high fever of 101 degrees F, weakness, fatigue, congested and headache. The patient completely recovered within 1 to 2 business days. The patient had only completed one dose of the BEXSERO. The patient was put on Intravenous medication. No further details were provided. Lab Comments: Lab test was done on an unspecified date.
pt recv vax 15AUG97 & took APAP w/some relief;had usual breakfast;vomited breakfast & nausea w/dizziness & h/a all day;still h/a;
Information has been received from a 64 year old female with codeine allergy and no medical history who on 08-NOV-2007 was vaccinated SC with first dose of zoster vaccine live (Oka/Merck). Concomitant therapy on same day but opposite arm included a dose of influenza virus vaccine (unspecified). Concomitant medications included (NASACORT), (ADVAIR), (MSD), (XANAX) and anti-depressant (unspecified). On 10-NOV-2007 the patient developed 3 X 1 inch red blotch near injection site. It was reported that the blotch was red, but there was no pain. The patient reported that the red blotch only itched when it was exposed to heat for example when taking a shower. No medical attention was sought. No diagnostic laboratory tests were undertaken. At the time of report the patient  had not recovered. A product quality was not involved. Additional information  has been requested. This is in follow-up to report(s) previously submitted on 12/21/2007.  Information has been received from a 64 year old female with codeine allergy and no medical history who on 08-NOV-2007 was vaccinated SC with first dose of ZOSTAVAX (Merck) (lot# "0966").  Concomitant therapy on same day but opposite arm included a dose of influenza virus vaccine (unspecified).  Concomitant medications included NASACORT, ADVAIN, OMEPROZOLE (MSD), XANAX and anti-depressant (unspecified).  On 10-NOV-2007 the patient developed 3 x 1 inch red blotch near injection site.  It was reported that the blotch was red, but there was no pain.  The patient reported that the red blotch only itched when it was exposed to heat for example when taking shower.  No medical attention was sought.  No diagnostic laboratory tests were undertaken.  At the time of report the patient had not recovered.  A product quality was not involved.  Additional information from the physician indicated that the patient did not inform him about any reaction but after receiving correspondence from us he called the patient and asked about the reaciton.  The patient stated that she had a red streak on her arm that lasted for one week, she had no further problems and did not received treatment for it.  Additional information is not expected.
(L) leg vaccine site red on 9-4-13 3:00 pm outlined by mom spread today (9-5-13) warm to touch. Cellulitis-afebrile 20x20 cm area - Rx AUGMENTIN.
Patient reported adverse events starting day after vaccine administration: pain at the injection site, muscle pain, redness, swelling, and swollen lymph nodes. Adverse events have not fully subsided as of today.
The day following the vaccine I developed a headache. Two days after the vaccine I developed tingling in extremities which was followed by numbness and burning sensations and fatigued muscles. I also developed a stiff neck that comes in waves.
I started having a fever had cramps in my belly & then I started having diarrhea & I was very confused so my husband took me to the ER I was DX with diverticulitis.
Injection date plus 7 days. Red raised rash at injection site. Hot to touch and itching.  Rash is 7 in length and 5cm in width. Arm pit soreness as well, both arms.
pt arched back, stiffened limbs;about 15seconds later, this resolved;pt did not remember this episode;pt was oriented to person, place & time following this;BP 110/80, pulse 80, R28/min;
Diarrhea; Nausea; Vomiting within 72 hours of the shot; This is a spontaneous report received from a contactable consumer (patient). A 43-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in arm left on 15Jul2021 14:15 (at the age of 43 years) (Batch/Lot Number: FA6780) as a single dose for COVID-19 immunization. Medical history included hypertension. Patient is not pregnant at the time of vaccination. Concomitant medications included losartan; cetirizine hydrochloride, pseudoephedrine hydrochloride (ZYRTEC); and omeprazole magnesium (PRILOSEC). On 18Jul2021 14:00 , the patient experienced diarrhea with outcome of recovered with sequelae and nausea and vomiting within 72 hours of the shot with outcome of recovered in Jul2021. Nausea and vomiting lasted around 18 hours. Diarrhea continued but is not as frequent as onset. No treatment was received for the adverse events. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Patient has not been tested for COVID-19 since the vaccination. Patient has no known allergies.  Follow-up attempts are completed. No further information is expected.
ABOUT 45 MINUTES AFTER VACCINE DEVELOPED GENERALIZED ITCHING; SCATTERED HIVES ON NECK, FACE, L LEG, R MID BACK; GAVE 50MG BENADRYL PO, BEGAN TO RESOLVE 20 MINUTES LATER, RESOLVED NEXT DAY, GENERAL MALAISE , DIARRHEA X 2 DAYS.
Fever, severe body aches, chills, diarrhea, stomach ache from 5:30pm to 1:30am on 4/10/21
This case was reported by a consumer via call center representative and described the occurrence of fatigue in a 73-year-old male patient who received SHINGRIX for prophylaxis. Concomitant products included nebivolol hydrochloride (Bystolic), rosuvastatin calcium (Crestor), warfarin sodium (Warfarin), lisinopril and torasemide (Torsemide). On 14th May 2018 17:00, the patient received the 1st dose of SHINGRIX (intramuscular). On 14th May 2018, immediately after receiving SHINGRIX the patient experienced headache. On 15th May 2018, the patient experienced fatigue, stiff neck, sleeplessness, wry neck, neck pain, fever and night sweats. On an unknown date, the outcome of the fatigue was recovered/resolved and the outcome of the headache, stiff neck, sleeplessness, wry neck, neck pain, fever and night sweats were recovering/resolving. The reporter considered the fatigue and headache to be probably related to SHINGRIX. The reporter considered the stiff neck, sleeplessness, wry neck, neck pain, fever and night sweats to be possibly related to SHINGRIX. Additional information was reported as follows: At 17:00 the patient was vaccinated with SHINGRIX at left deltoid. This case was reported by the patient's spouse. He experienced fatigue and slept all the next day, after vaccination.  He developed a headache immediately and was unable to turn his head. He could not sleep at night for over a week, after vaccination. The wry neck symptom started on the left side of his neck and moved to the right side. He still had sore neck at the time of reporting. The patient did not had any plan of receiving the 2nd dose of SHINGRIX. This case was linked to case US2018101637 (wife case), reported by the same reporter.
MENACTRA given 5/4/11. Rash 5/5/11. Temp 99.8 5/6/11. Info gathered by TPC.
Short of breath; Poor sleep (apnea); Chills; Cough in AIM; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Short of breath), SLEEP APNOEA SYNDROME (Poor sleep (apnea)), COUGH (Cough in AIM) and CHILLS (Chills) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     The patient's past medical history included Cough on 07-Jan-2021. Concomitant products included Blood Thinners, DASATINIB MONOHYDRATE (SPRYCEL) and Pacemaker for an unknown indication.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced COUGH (Cough in AIM). On 08-Jan-2021, the patient experienced DYSPNOEA (Short of breath), SLEEP APNOEA SYNDROME (Poor sleep (apnea)) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, DYSPNOEA (Short of breath), SLEEP APNOEA SYNDROME (Poor sleep (apnea)), COUGH (Cough in AIM) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
in first 24 hours of administration of vaccines pt has developed nausea/vomiting/bodyache a fever of 101 degree F. Zofran was prescribed for nausea/vomiting along with hydration.
Pain at injection site; severe Stomach pain; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 62-year-old female patient who received Herpes zoster (Shingrix) (batch number 592RY, expiry date 31st August 2023) and (batch number 5392T, expiry date 31st August 2023) for prophylaxis.   On 16th June 2022, the patient received the 1st dose of Shingrix. On an unknown date, the dose was an unknown dose. In June 2022, less than a day after receiving Shingrix, the patient experienced stomach pain. On an unknown date, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain and stomach pain were recovered/resolved.   It was unknown if the reporter considered the injection site pain and stomach pain to be related to Shingrix.     Linked case(s) involving the same patient:  US2022126895   Additional Information: GSK Receipt Date: 01-SEP-2022 and 02-SEP-2022 Reporter's comment: The patient self-reported this case. The patient received dose of Shingrix vaccine and experienced pain at the injection site and stomach pain. Less than a day after vaccination the patient experinced stomach pain.  The patient reported stomach pain began in the middle of the night and lasted approximately 3 days. The reporter consented to follow-up. For tolerance of 2nd dose refer case US2022126895; Sender's Comments:  US-GSK-US2022126895:Same reporter
itched all nigh; got the flu a week later; sick; Initial information received on 19-Sep-2023 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp (Non-healthcare professional).  This case involves an unknown age and unknown gender patient who itched all nigh, got the flu a week later and sick after receiving Influenza Vaccine.  The patient's past medical treatment(s), vaccination(s) and family history were not provided. It is unknown if the patient had any medical history, medical treatment (s), concomitant disease or risk factor.   On an unknown date, the patient received an unknown dose of suspect Influenza Vaccine produced by unknown manufacturer (with an unknown strength, expiry date, formulation and lot number) via unknown route in unknown administration site for prophylactic vaccination (Immunisation).  On an unknown date, the patient itched all nigh (pruritus), got the flu a week later (influenza) and sick (illness) (unknown latency).  It is unknown if the patient experienced any additional symptoms/events  It is unknown if there were lab data/results available.  It was reported, This is a social media case received Description: Not this year. I had my first reaction last year. I itched all nigh, got the flu a week later. I was sick as could be.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the events.  At time of reporting, the outcome was Unknown for the events
No adverse effects reported.; patient received extra dose of VARIVAX concomitantly with PROQUAD; This spontaneous report was received from a nurse regarding a patient of unknown age and gender. There was no information reported about the patient's concomitant medications, pertinent medical history and drug reactions or allergies.   On 24-SEP-2019, the patient received an extra dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (Lot No. S005079 has been verified to be a valid lot number, expiration date not reported, but upon internal validation established as 19-FEB-2021), concomitantly with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot number and expiration date were not provided) for prophylaxis (dose and route of administration were not reported). No adverse effects were reported.